Takeda: Narcolepsy trials

The registry lists 10 Narcolepsy studies with Takeda as lead sponsor. 1 are open to participants now and 7 have results posted.

Phase 1 2Phase 2 5Phase 3 1No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)RecruitingNCT07633301Phase 2
• A Study of TAK-861 in Participants With Narcolepsy Type 2CompletedNCT05687916Phase 2Results posted
• A Study of TAK-861 in Participants With Narcolepsy Type 1CompletedNCT05687903Phase 2Results posted
• A Study of TAK-994 in Adults With NarcolepsyTerminatedNCT04820842Phase 2Results posted
• A Study to Collect Information of People With Narcolepsy in SpainCompletedNCT04667338Results posted
• A Study of TAK-994 in Adults With Type 1 and Type 2 NarcolepsyTerminatedNCT04096560Phase 2Results posted
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAK-925 in Healthy Volunteers and Participants With NarcolepsyCompletedNCT03748979Phase 1Results posted
• Phase 1 TAK-925 Study in Healthy Adult and Elderly Volunteers and Participants With NarcolepsyCompletedNCT03332784Phase 1Results posted
• A Trial of TAK-861 for the Treatment of Narcolepsy With CataplexyActive, not recruitingNCT07363720Phase 3
• Wake and Sleep State Transitions on a Portable Electroencephalogram (EEG) Device in Narcolepsy Type 1 (NT1) and Healthy ParticipantsCompletedNCT04445129